Kaifu Gao,Rui Wang,Jiahui Chen,Limei Cheng,Jaclyn Frishcosy,Yuta Huzumi,Yuchi Qiu,Tom Schluckbier,Guo-Wei Wei
Abstract:The deadly coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gone out of control globally. Despite much effort by scientists, medical experts, and society in general, the slow progress on drug discovery and antibody therapeutic development, the unknown possible side effects of the existing vaccines, and the high transmission rate of the SARS-CoV-2, remind us of the sad reality that our current understanding of the transmission, infectivity, and evolution of SARS-CoV-2 is unfortunately very limited. The major limitation is the lack of mechanistic understanding of viral-host cell interactions, the viral regulation, protein-protein interactions, including antibody-antigen binding, protein-drug binding, host immune response, etc. This limitation will likely haunt the scientific community for a long time and have a devastating consequence in combating COVID-19 and other pathogens. Notably, compared to the long-cycle, highly cost, and safety-demanding molecular-level experiments, the theoretical and computational studies are economical, speedy, and easy to perform. There exists a tsunami of the literature on molecular modeling, simulation, and prediction of SARS-CoV-2 that has become impossible to fully be covered in a review. To provide the reader a quick update about the status of molecular modeling, simulation, and prediction of SARS-CoV-2, we present a comprehensive and systematic methodology-centered narrative in the nick of time. Aspects such as molecular modeling, Monte Carlo (MC) methods, structural bioinformatics, machine learning, deep learning, and mathematical approaches are included in this review. This review will be beneficial to researchers who are looking for ways to contribute to SARS-CoV-2 studies and those who are assessing the current status in the field.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the current insufficient understanding of the molecular mechanisms of SARS - CoV - 2 (the virus that causes COVID - 19), especially the lack of knowledge in aspects such as the interaction between the virus and host cells, the virus's regulation of host cell functions and the immune system, protein - protein interactions, antibody - antigen binding, protein - drug binding, and the host immune response. These deficiencies have hindered in - depth understanding of the spread, infectivity, and evolution of SARS - CoV - 2, and thus affected the discovery of effective drugs against this virus, the development of antibody therapies, and the evaluation of vaccine side effects.
Specifically, the paper points out that despite the great efforts of scientists, medical experts, and all sectors of society, there are still no effective methods to control, prevent, and cure COVID - 19 at present. The discovery of small - molecule drugs and the development of antibody therapies are progressing slowly, and the existing vaccines may have unknown side effects, especially long - term side effects. In addition, nearly 30,000 unique mutations of SARS - CoV - 2 have been recorded, which further reveals the serious deficiency in our knowledge in the fields of life sciences, virology, epidemiology, and medicine.
To address these problems, the paper emphasizes making up for the deficiencies of experimental research from the perspective of molecular modeling, simulation, and prediction by using theoretical and computational studies. These computational methods are more economical, faster, and easier to perform compared with traditional molecular - level experiments. Therefore, by reviewing the applications of molecular modeling, the Monte Carlo (MC) method, structural bioinformatics, machine learning and deep learning, and mathematical methods in SARS - CoV - 2 research, this paper aims to provide researchers with the latest research progress, help them better understand the molecular mechanisms of SARS - CoV - 2, and provide guidance for future scientific research work.